Could an HIV drug tame the virus linked to multiple sclerosis?
NCT ID NCT05957913
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 25 times
Summary
This study tests whether Truvada, an antiviral drug that fights Epstein-Barr virus (EBV), can reduce EBV levels in saliva and blood of 50 adults with multiple sclerosis (MS). Researchers also want to see if the drug is safe and tolerable for people with MS. The goal is to understand if controlling EBV could help manage MS.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.